Purchase Order 75N91021P00920
Award Date 9/23/21
Potential Completion Date 9/22/25
Potential Value $235K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order contract valued at $300,280.00 to Illumina, Inc. for maintenance services on Illumina NextSeq 500 genomic sequencing equipment. The contract has a completion date of May 18, 2023 and was awarded on May 19, 2018. Illumina, a for-profit manufacturer of genomic analysis instruments and reagents, has been awarded numerous prime and subcontract federal awards...
- This is a $145,853.00 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Illumina, Inc. The contract is for a maintenance agreement for scientific equipment, specifically Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems and related reagents and consumables. Illumina is a for-profit manufacturer that has provided a range of genomic sequencing and analysis products and services...
- This is a $114,198.14 firm fixed price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for their NextSeq 550 comprehensive service plan. The contract is not set aside and has an ultimate completion date of July 31, 2024. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously received prime federal contracts and subcontracts from agencies...
- This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment. The contract provides for an equipment maintenance agreement on Illumina sequencing systems, such as NextSeq, NovaSeq, MiSeq, and iSeq models, with a ceiling value of $16,198.00 and a performance period ending on December 4, 2025. The contract does...
- This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of biological kits and Illumina sequencing systems and consumables. The $99,470.50 contract has an ultimate completion date of September 6, 2017 and does not have a set-aside designation. Illumina is a for-profit manufacturer of genomic analysis instruments and reagents that has previously received...
- This contract was awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $24,797.20 firm-fixed-price delivery order is for Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis research and diagnostics. No set-aside was used. Illumina has a history of providing these types of products and services to...
- This federal contract award, valued at $81,706.00, was granted to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract is for preventive maintenance, emergency service, and support for a government-owned Illumina NextSeq 550 sequencer in support of the NCI's Center for Cancer Research...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $24,230.96 contract provides Illumina sequencing systems, reagents, and services to support genomic research and diagnostics. The award is not associated with a set-aside program. Through past prime contract and subcontract awards, Illumina has...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, an agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $12,103.44 contract has a completion date of September 29, 2025 and does not utilize a set-aside designation. Illumina provides a range of genomic sequencing platforms, reagents, consumables, and maintenance services to support...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc. to maintain and provide preventive maintenance for an Illumina NextSeq 2000 sequencing system. The contract has a ceiling value of $48,209.00 and a performance period ending on March 19, 2026. Illumina is a manufacturer of genetic sequencing and analysis instruments and reagents, and has a history of providing such products and...